Previous Section
Clinical Trials
31. A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma.
- Author
- Yeo W; Mok TS; Zee B; Leung TW; Lai PB; Lau WY; Koh J; Mo FK; Yu SC; Chan AT; Hui P; Ma B; Lam KC; Ho WM; Wong HT; Tang A; Johnson PJ;
- Institution
- Department of Clinical Oncology, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China.
- Journal
- J Natl Cancer Inst. 2005 Oct 19;97(20):1532-8.
- Abstract URL
- Click here to view abstract
32. Phase II study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancer.
- Author
- Philip PA; Mahoney MR; Allmer C; Thomas J; Pitot HC; Kim G; Donehower RC; Fitch T; Picus J; Erlichman C;
- Institution
- Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201, USA. philipp@karmanos.org
- Journal
- J Clin Oncol. 2005 Sep 20;23(27):6657-63.
- Abstract URL
- Click here to view abstract
33. Natural history of untreated nonsurgical hepatocellular carcinoma.
- Author
- Yeung YP; Lo CM; Liu CL; Wong BC; Fan ST; Wong J;
- Institution
- Department of Surgery, Kwong Wah Hospital, and Centre for the Study of Liver Disease, China.
- Journal
- Am J Gastroenterol. 2005 Sep;100(9):1995-2004.
- Abstract URL
- Click here to view abstract
34. Phase II study of sorafenib in patients with advanced hepatocellular carcinoma.
- Author
- Abou-Alfa GK; Schwartz L; Ricci S; Amadori D; Santoro A; Figer A; De Greve J; Douillard JY; Lathia C; Schwartz B; Taylor I; Moscovici M; Saltz LB;
- Institution
- Memorial Sloan-Kettering Cancer Center, York, NY 10022, USA. abou-alg@mskcc.org
- Journal
- J Clin Oncol. 2006 Sep 10;24(26):4293-300. Epub 2006 Aug 14.
- Abstract URL
- Click here to view abstract
35. Do young hepatocellular carcinoma patients have worse prognosis? The paradox of age as a prognostic factor in the survival of hepatocellular carcinoma patients.
- Author
- Chen CH; Chang TT; Cheng KS; Su WW; Yang SS; Lin HH; Wu SS; Lee CM; Changchien CS; Chen CJ; Sheu JC; Chen DS; Lu SN;
- Institution
- Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
- Journal
- Liver Int. 2006 Sep;26(7):766-73.
- Abstract URL
- Click here to view abstract
36. Pegylated liposomal doxorubicin-based combination chemotherapy as salvage treatment in patients with advanced hepatocellular carcinoma.
- Author
- Poh SB; Bai LY; Chen PM;
- Institution
- Division of Medical Oncology, Department of Medicine, Taipei Veterans General Hospital, and the National Yang-Ming University Taipei, Taiwan.
- Journal
- Am J Clin Oncol. 2005 Dec;28(6):540-6.
- Abstract URL
- Click here to view abstract
37. Pharmacokinetic and clinical phase II trial of imatinib in patients with impaired liver function and advanced hepatocellular carcinoma.
- Author
- Eckel F; von Delius S; Mayr M; Dobritz M; Fend F; Hosius C; Schleyer E; Schulte-Frohlinde E; Schmid RM; Lersch C;
- Institution
- Department of Internal Medicine II, Klinikum rechts der Isar, Technical University of Munich, Germany. florian.eckel@lrz.tum.de
- Journal
- Oncology. 2005;69(5):363-71. Epub 2005 Nov 24.
- Abstract URL
- Click here to view abstract
Next: Radiation Therapy
